The Novavax vaccine is currently in intermediate stage (representative) trials US drug developer Novavax said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with the Serum Institute of India, which would increase its shares around 7 %. In August, …
Read More »US company Novavax targets 2 billion doses of coronavirus vaccines with expanded deal in India
